Current evidence indicates that approximately 76% of the global population remains below adequate omega-3 intake thresholds, specifically falling short of the 250 mg/day EPA+DHA baseline recommendation. This finding underscores a significant nutritional adequacy gap that dietary sources alone cannot address for most individuals.
The prevalence of suboptimal omega-3 status reflects broader challenges in translating nutritional guidelines into population-level health outcomes. Unlike optimization goals, which aim to exceed baseline requirements, this data emphasizes the basic inadequacy affecting the majority of adults worldwide.
These 2025 findings highlight the need for evidence-based supplementation strategies and targeted dietary interventions to address this widespread deficiency. Healthcare providers should consider screening and intervention protocols that acknowledge both dietary limitations and individual variability in omega-3 metabolism.
Was this article helpful?
